FTC Bill And Abbvie

Quote

anonymous

Guest
President Trump today signed an FTC bill to enhance the Medicare Modernization Act of 2003, and the Patients Right to Know Drug Prices Act. This is NOT good news for Rick. AbbVie reached deals with Amgen, Samsung Bioepis and Mylan, to fend off U.S. competition until 2023. Now, the FTC will investigate for antitrust scrutiny. FTC will be able to access the terms of these deals without needing to seek additional authority from the commission. Abbvie and Humira are thier
#1 Target !!!!! Stocks ready to take a HUGE HIT.
Biosims ARE being launched in Europe NEXT WEEK.
 


















LETS NOT FORGET WHAT HAPPENED ON JUNE 29TH WITH ANDRO AND HOW FTC RULED
AbbVie was hit with a $448 million judgement for allegedly overcharging consumers, according to the Federal Trade Commission. In 2014, the FTC alleged AbbVie and its partner Besins Healthcare Inc. blocked consumer access to lower cost versions of the testosterone replacement drug Androgel. The FTC accused AbbVie of using "sham litigation" to maintain its monopoly. AbbVie has previously denied the allegations and the breakdown of relief between AbbVie and Besins was not immediately clear. "This decision is a double victory, both for patients who rely on Androgel and for competition more broadly," said FTC chairman Joe Simons. "It sends a clear signal that pharmaceutical companies can't use baseless litigation to forestall competition from low-cost generics." The decision handed down in the U.S. District Court for Eastern Pennsylvania is the largest monetary award in a litigated FTC antitrust case, the agency said
 












Are you serious? After the FTC bill and pending antitrust investigation Abbvie pulls this insane move today along with press release below? Ricks just asking for a kick in the balls by FTC and he's gonna get it. UNFORTUNATELY, the shareholder WILL suffer from this extreme incompetence.

Under the terms of the settlement agreements, AbbVie will grant to Sandoz a non-exclusive license to AbbVie's intellectual property relating to HUMIRA beginning on certain dates in certain countries in which AbbVie has intellectual property. The license period will begin on September 30, 2023 in the U.S., and will not be accelerated by the entry of companies who have already taken a license. The license will begin on October 16, 2018 in most countries in the European Union, and on other dates in various countries in which AbbVie has intellectual property.

Sandoz will pay royalties to AbbVie for licensing its HUMIRA patents and acknowledges the validity of the licensed patents. AbbVie will make no payments to Sandoz. The precise terms are confidential between the parties. All litigation pending between the parties will be dismissed.

"AbbVie's HUMIRA patents reflect the groundbreaking work of AbbVie scientists in the field of fully-human biologics and our investment in patient-focused innovation," said Laura Schumacher, executive vice president, external affairs, general counsel and corporate secretary, AbbVie. "We continue to believe biosimilars will play an important role in our healthcare system, but we also believe it is important to protect our investment in innovation. This agreement accomplishes both objectives."
 






Schumacher Is lying through her teeth. “Humira is the groundbreaking work of Abbvie scientists” ? Bullshit ! Knoll R&D discovered D2E7 and both Abbott Labs and Abbvie R&D couldn’t discover a turd in a toilet. That’s why white dumped Abbots R&D along with a drug whis days were numbered What gall these corporate Abbvie leech liars have.

"AbbVie's HUMIRA patents reflect the groundbreaking work of AbbVie scientists in the field of fully-human biologics and our investment in patient-focused innovation," said Laura Schumacher, executive vice president, external affairs, general counsel and corporate secretary, AbbVie. "We continue to believe biosimilars will play an important role in our healthcare system, but we also believe it is important to protect our investment in innovation. This agreement accomplishes both objectives.
 






















































Looks like my old colleague Bill Chase has had enough. Bob Michael is taking over next year and Durkin is shuffled into mix ? Theres a shakeup in C Suite. Good luck Bill I remember in 93 i thought you were a great hire and was proud to work with you.

More bad news below
AbbVie Inc
NYSE: ABBV
89.10 USD −0.85 (0.94%)

 






anonymous said:
Schumacher Is lying through her teeth. “Humira is the groundbreaking work of Abbvie scientists” ? Bullshit ! Knoll R&D discovered D2E7 and both Abbott Labs and Abbvie R&D couldn’t discover a turd in a toilet. That’s why white dumped Abbots R&D along with a drug whis days were numbered What gall these corporate Abbvie leech liars have.

"AbbVie's HUMIRA patents reflect the groundbreaking work of AbbVie scientists in the field of fully-human biologics and our investment in patient-focused innovation," said Laura Schumacher, executive vice president, external affairs, general counsel and corporate secretary, AbbVie. "We continue to believe biosimilars will play an important role in our healthcare system, but we also believe it is important to protect our investment in innovation. This agreement accomplishes both objectives.
Click to expand...

Will you please stop? You got your payday. Just leave us alone. We are trying to advance our position with investors and employees and you are divulging trade secrets, disparaging us and posting confidential information. You signed an agreement and broke it on here. Lucky your boys club frat pal here in chicago is scared of you. Be careful if and when he leaves.
 






anonymous said:
Will you please stop? You got your payday. Just leave us alone. We are trying to advance our position with investors and employees and you are divulging trade secrets, disparaging us and posting confidential information. You signed an agreement and broke it on here. Lucky your boys club frat pal here in chicago is scared of you. Be careful if and when he leaves.
Click to expand...

Can’t keep a good man down Missy. Better watch your own ass sweetheart.
 






anonymous said:
Will you please stop? You got your payday. Just leave us alone. We are trying to advance our position with investors and employees and you are divulging trade secrets, disparaging us and posting confidential information. You signed an agreement and broke it on here. Lucky your boys club frat pal here in chicago is scared of you. Be careful if and when he leaves.
Click to expand...

Hey Toots, did you wake up on the wrong side of the rainbow? You won’t do jackshit !!!
I’ll have your sorry ass fired with one phone call.
 












Top Bottom
Back
Quote